The Spanish government has today announced a further € 1 million contribution to UNAIDS to support its work to end AIDS by ...
In order to counter such stigma and discrimination, women living with HIV and Hepatitis B came together at The Voice of ...
This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...
There was a huge backlash,” remembered Dr Nittaya Phanuphak, the Executive Director of the Institute of HIV Research and Innovation (IHRI). She was telling the story from IHRI’s sunlit offices to ...
Note: ViiV’s announcement can be read on their site at ...
unaids.org UNAIDS There are around 1.4 million people living with HIV in China and women make up around 23.
New long-acting technologies are changing the HIV prevention landscape. In recent years, innovation in pre-exposure prophylaxis (PrEP) has accelerated. Long acting injectable cabotegravir and the ...